Cytomx Thera (CTMX)

$4.56 0.00 (N/A)
Market Cap 776.05M
Revenue (ttm) 76.20M
Net Income (ttm) -17.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -22.80%
Debt to Equity Ratio 0.00
Volume 4,718,100
Avg Vol 7,330,630
Day's Range N/A - N/A
Shares Out 170.19M
Stochastic %K 61%
Beta 2.49
Analysts Strong Sell
Price Target $13.67

Company Profile

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators,...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 515 3185
Fax: 650 351 0353
Address:
151 Oyster Point Boulevard, Suite 400, South San Francisco, United States
Turdsniffer
Turdsniffer Apr. 4 at 6:04 PM
$CTMX monday gonna be a bloody mess. President Turd gonna crush entire market and economy. I can’t believe I voted and got duped by this pdfile piece of shit scumbag war criminal. Thanks dickhead
0 · Reply
Gator5326
Gator5326 Apr. 3 at 1:23 PM
$CTMX Potential game changer with continued positive data. 😎
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 2 at 7:43 PM
$CTMX RSI: 48.45, MACD: -0.1897 Vol: 0.55, MA20: 4.74, MA50: 5.20 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
2 · Reply
ccledez
ccledez Apr. 2 at 3:39 PM
$CTMX good pipeline. If their drug works (which seems to be), this will be a blockbuster
0 · Reply
bryantboy99
bryantboy99 Apr. 2 at 12:40 PM
$CTMX https://x.com/realPatrickJr/status/2039379345043816502?s=20
1 · Reply
Turdsniffer
Turdsniffer Apr. 1 at 3:13 PM
$CTMX fuck thus turd..
4 · Reply
pdolum
pdolum Apr. 1 at 1:48 PM
$CTMX $5 today!
0 · Reply
Turdsniffer
Turdsniffer Mar. 31 at 8:11 PM
$CTMX we were at .45c a year ago.. tough times 💪
0 · Reply
dsnakes
dsnakes Mar. 31 at 4:32 PM
$CTMX barely over a mil volume 🐌
0 · Reply
CAN29
CAN29 Mar. 31 at 4:28 PM
$CTMX We still have to get past/digest the recent $5.30 public offering before people get back to the Varseta-M‘s potential.
0 · Reply
Latest News on CTMX
Why Is CytomX Therapeutics Stock Falling On Wednesday?

Mar 18, 2026, 1:06 PM EDT - 17 days ago

Why Is CytomX Therapeutics Stock Falling On Wednesday?

CytomX Therapeutics: Great News, But Early Data Do Not Quite Justify This Price Level

Mar 18, 2026, 10:03 AM EDT - 17 days ago

CytomX Therapeutics: Great News, But Early Data Do Not Quite Justify This Price Level

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

Mar 17, 2026, 10:46 PM EDT - 17 days ago

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Mar 16, 2026, 4:04 PM EDT - 19 days ago

CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

CytomX: The Probody Mask Just Slipped, And Investors Like What They See (Upgrade)

Mar 16, 2026, 1:59 PM EDT - 19 days ago

CytomX: The Probody Mask Just Slipped, And Investors Like What They See (Upgrade)

Mid-Cap CytomX Therapeutics' Colorectal Cancer Data Fuels Stock Rally

Mar 16, 2026, 12:38 PM EDT - 19 days ago

Mid-Cap CytomX Therapeutics' Colorectal Cancer Data Fuels Stock Rally

CytomX Therapeutics, Inc. (CTMX) Q4 2025 Earnings Call Transcript

Mar 16, 2026, 12:03 PM EDT - 19 days ago

CytomX Therapeutics, Inc. (CTMX) Q4 2025 Earnings Call Transcript

CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update

Mar 16, 2026, 7:05 AM EDT - 19 days ago

CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update

CytomX's Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer

Mar 16, 2026, 7:00 AM EDT - 19 days ago

CytomX's Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer

CytomX Therapeutics Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Mar 16, 2026, 1:25 AM EDT - 19 days ago

CytomX Therapeutics Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Mar 4, 2026, 8:00 AM EST - 4 weeks ago

CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

CytomX Therapeutics to Present at Upcoming February Conferences

Feb 4, 2026, 8:00 AM EST - 2 months ago

CytomX Therapeutics to Present at Upcoming February Conferences

Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

Jan 27, 2026, 7:00 AM EST - 2 months ago

Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

CRDF

Wareham Development Leases Full Floor at EmeryStation Research Campus to CytomX Therapeutics

Jan 21, 2026, 3:00 PM EST - 2 months ago

Wareham Development Leases Full Floor at EmeryStation Research Campus to CytomX Therapeutics

CytomX Therapeutics, Inc. (CTMX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 2:36 PM EST - 2 months ago

CytomX Therapeutics, Inc. (CTMX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CytomX Therapeutics Announces Business Update and Company Milestones for 2026

Jan 8, 2026, 8:00 AM EST - 3 months ago

CytomX Therapeutics Announces Business Update and Company Milestones for 2026

CytomX: Easiest Money May Have Been Made, Although Pipeline Remains Compelling

Dec 15, 2025, 1:46 AM EST - 3 months ago

CytomX: Easiest Money May Have Been Made, Although Pipeline Remains Compelling

CytomX Therapeutics to Present at Upcoming December Investor Conferences

Nov 25, 2025, 8:00 AM EST - 4 months ago

CytomX Therapeutics to Present at Upcoming December Investor Conferences

CytomX Therapeutics: Leaning Into The Hype, But What's Next?

Nov 18, 2025, 9:32 AM EST - 4 months ago

CytomX Therapeutics: Leaning Into The Hype, But What's Next?

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 5 months ago

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

Targeting Adhesion Molecules With ADC's: The Bet Of CytomX

Nov 11, 2025, 4:04 AM EST - 5 months ago

Targeting Adhesion Molecules With ADC's: The Bet Of CytomX

CytomX Therapeutics, Inc. (CTMX) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 2:26 PM EST - 5 months ago

CytomX Therapeutics, Inc. (CTMX) Q3 2025 Earnings Call Transcript

CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

Nov 6, 2025, 4:10 PM EST - 5 months ago

CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

Top Biotech Stocks Riding The Rally

Nov 4, 2025, 3:15 PM EST - 5 months ago

Top Biotech Stocks Riding The Rally

GRAL GRFS INCY

CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 4, 2025, 9:15 AM EST - 5 months ago

CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 30, 2025, 8:00 AM EDT - 5 months ago

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer

Oct 20, 2025, 4:05 PM EDT - 5 months ago

CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer

CytomX Therapeutics: Additional Run Up Into The Q1 2026 Readout Is Possible

Oct 13, 2025, 11:45 PM EDT - 6 months ago

CytomX Therapeutics: Additional Run Up Into The Q1 2026 Readout Is Possible

Renewed Tariff Fears Spotlight Top Performing Stocks Since April

Oct 12, 2025, 5:00 AM EDT - 6 months ago

Renewed Tariff Fears Spotlight Top Performing Stocks Since April

NVDA PSIX SMH VSAT

CytomX: A Fresh Start With New Drugs After Total Pipeline Failure

Oct 6, 2025, 11:20 AM EDT - 6 months ago

CytomX: A Fresh Start With New Drugs After Total Pipeline Failure

CytomX Therapeutics, Inc. (CTMX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 4:26 PM EDT - 7 months ago

CytomX Therapeutics, Inc. (CTMX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

CytomX Therapeutics to Present at Upcoming September Investor Conferences

Aug 28, 2025, 8:00 AM EDT - 7 months ago

CytomX Therapeutics to Present at Upcoming September Investor Conferences

CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study

Aug 13, 2025, 8:00 AM EDT - 8 months ago

CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study

CytomX Therapeutics, Inc. (CTMX) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 6:10 PM EDT - 8 months ago

CytomX Therapeutics, Inc. (CTMX) Q2 2025 Earnings Call Transcript

CytomX Therapeutics: Updated Outlook For Late 2025

Aug 8, 2025, 5:05 PM EDT - 8 months ago

CytomX Therapeutics: Updated Outlook For Late 2025

CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

Aug 7, 2025, 4:10 PM EDT - 8 months ago

CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 31, 2025, 8:00 AM EDT - 8 months ago

CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

May 29, 2025, 8:00 AM EDT - 11 months ago

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma

May 19, 2025, 8:00 AM EDT - 11 months ago

CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma

CytomX Therapeutics: Doubling Overnight On Phase 1 Data

May 13, 2025, 10:34 AM EDT - 11 months ago

CytomX Therapeutics: Doubling Overnight On Phase 1 Data

CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript)

May 12, 2025, 2:40 PM EDT - 11 months ago

CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript)

Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Report

May 12, 2025, 11:11 AM EDT - 11 months ago

Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Report

CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

May 12, 2025, 6:50 AM EDT - 11 months ago

CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC)

May 12, 2025, 6:15 AM EDT - 11 months ago

CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC)

CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 6:15 AM EDT - 11 months ago

CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025

May 5, 2025, 8:00 AM EDT - 11 months ago

CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

Apr 28, 2025, 4:00 PM EDT - 1 year ago

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

CytomX Therapeutics, Inc. (CTMX) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 6:34 PM EST - 1 year ago

CytomX Therapeutics, Inc. (CTMX) Q4 2024 Earnings Call Transcript

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

Mar 6, 2025, 4:10 PM EST - 1 year ago

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference

Mar 5, 2025, 8:00 AM EST - 1 year ago

CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference

Turdsniffer
Turdsniffer Apr. 4 at 6:04 PM
$CTMX monday gonna be a bloody mess. President Turd gonna crush entire market and economy. I can’t believe I voted and got duped by this pdfile piece of shit scumbag war criminal. Thanks dickhead
0 · Reply
Gator5326
Gator5326 Apr. 3 at 1:23 PM
$CTMX Potential game changer with continued positive data. 😎
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 2 at 7:43 PM
$CTMX RSI: 48.45, MACD: -0.1897 Vol: 0.55, MA20: 4.74, MA50: 5.20 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
2 · Reply
ccledez
ccledez Apr. 2 at 3:39 PM
$CTMX good pipeline. If their drug works (which seems to be), this will be a blockbuster
0 · Reply
bryantboy99
bryantboy99 Apr. 2 at 12:40 PM
$CTMX https://x.com/realPatrickJr/status/2039379345043816502?s=20
1 · Reply
Turdsniffer
Turdsniffer Apr. 1 at 3:13 PM
$CTMX fuck thus turd..
4 · Reply
pdolum
pdolum Apr. 1 at 1:48 PM
$CTMX $5 today!
0 · Reply
Turdsniffer
Turdsniffer Mar. 31 at 8:11 PM
$CTMX we were at .45c a year ago.. tough times 💪
0 · Reply
dsnakes
dsnakes Mar. 31 at 4:32 PM
$CTMX barely over a mil volume 🐌
0 · Reply
CAN29
CAN29 Mar. 31 at 4:28 PM
$CTMX We still have to get past/digest the recent $5.30 public offering before people get back to the Varseta-M‘s potential.
0 · Reply
Turdsniffer
Turdsniffer Mar. 31 at 11:17 AM
$CTMX just get green already 😐
1 · Reply
pdolum
pdolum Mar. 30 at 6:54 PM
$CTMX no volume
3 · Reply
Chrissytina
Chrissytina Mar. 30 at 2:35 PM
$CTMX I get the whole pump & dump on earnings announcement but there’s no reason why this isn’t back to the pre pump prices…$5.50 😡
2 · Reply
BioTechHealthX
BioTechHealthX Mar. 29 at 9:34 AM
$CTMX CytomX Therapeutics (NASDAQ: CTMX) is backed by pharma giants like Amgen and Bristol Myers Squibb. With cutting-edge cancer tech and strong partnerships, this micro-cap biotech may be undervalued. https://biotechhealthx.com/biotech-news/is-it-worthy-to-invest-in-cytomx-therapeutics-ctmx/
0 · Reply
CAN29
CAN29 Mar. 27 at 5:17 PM
$CTMX Decent move up in a terrible overall day 🤔
1 · Reply
BioTechHealthX
BioTechHealthX Mar. 27 at 3:20 PM
$CAMP $CNTX $CTMX $GALT $IMUX Looking for high-growth biotech stocks? These micro-cap companies are showing strong momentum, active catalysts, and rising investor interest—making them top candidates for another surge. https://biotechhealthx.com/biotech-news/top-10-trending-micro-cap-biotech-stocks-to-watch-today/
0 · Reply
bryantboy99
bryantboy99 Mar. 27 at 10:13 AM
$CTMX I should have looked deeper on Vanguard's 13G filing. Disregard my post from yesterday afternoon.
1 · Reply
bryantboy99
bryantboy99 Mar. 26 at 10:47 PM
$CTMX Vanguard sold all of their 9 million shares.
5 · Reply
STACKD0E
STACKD0E Mar. 26 at 2:09 PM
$CTMX 🙃✨
0 · Reply
Turdsniffer
Turdsniffer Mar. 26 at 12:47 PM
$CTMX thirsty turd Thursday
1 · Reply
Turdsniffer
Turdsniffer Mar. 25 at 7:29 PM
$CTMX ahhahha wtf?😂
1 · Reply
Mavi93
Mavi93 Mar. 25 at 7:20 PM
$CTMX Fundamentals haven’t changed at all, just +250M in cash now. Mid to long term this looks like a self runner. So stay relaxed there’s a lot of hedging going on right now because institutions are stepping in. $10 by year end is definitely on the table.
2 · Reply